Loading...

LOXL2

Simtuzumab is a humanized monoclonal antibody designed for the treatment of fibrosis. It binds to LOXL2 and acts as an immunomodulator.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

© 2007 - 2019 Creative BioLabs All Rights Reserved
  • 0
  • 0

Cart